184 related articles for article (PubMed ID: 21275969)
1. TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm.
Jardin F; Ruminy P; Parmentier F; Troussard X; Vaida I; Stamatoullas A; Leprêtre S; Penther D; Duval AB; Picquenot JM; Courville P; Capiod JC; Tilly H; Bastard C; Marolleau JP
Br J Haematol; 2011 May; 153(3):413-6. PubMed ID: 21275969
[No Abstract] [Full Text] [Related]
2. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.
Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S
Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980
[TBL] [Abstract][Full Text] [Related]
3. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.
Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH
Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384
[No Abstract] [Full Text] [Related]
4. Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
Li M; Shah M; Binder M; Lasho T; Carr R; Mangaonkar A; Gangat N; Coltro G; Tefferi A; Dao L; Peters M; Chiu A; Patnaik MM
Am J Hematol; 2020 Feb; 95(2):E31-E34. PubMed ID: 31705546
[No Abstract] [Full Text] [Related]
5. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
Kurt H; Khoury JD; Medeiros LJ; Huh YO
Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
[No Abstract] [Full Text] [Related]
6. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
7. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract][Full Text] [Related]
8. Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm.
Szczepaniak A; Machnicki M; Gniot M; Pępek M; Rydzanicz M; Płoski R; Kaźmierczak M; Stokłosa T; Lewandowski K
Int J Hematol; 2019 Jul; 110(1):102-106. PubMed ID: 30977107
[TBL] [Abstract][Full Text] [Related]
9. Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival.
Shimony S; Keating J; Fay CJ; Luskin MR; Neuberg DS; LeBoeuf NR; Lane AA
Blood Adv; 2024 Jun; 8(11):2803-2812. PubMed ID: 38603567
[TBL] [Abstract][Full Text] [Related]
10. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
[TBL] [Abstract][Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
Dang X; Zhou D; Meng L; Bi L
J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
[TBL] [Abstract][Full Text] [Related]
12. Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm.
Fiandrino G; Arra M; Riboni R; Lucioni M; Dallera E; Arcaini L; Berti E; Paulli M
Br J Dermatol; 2013 Apr; 168(4):883-4. PubMed ID: 23013250
[No Abstract] [Full Text] [Related]
13. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
[TBL] [Abstract][Full Text] [Related]
14. Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.
Li R; Xu MJ; Yang FC; Zhou Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):583-588. PubMed ID: 27825418
[TBL] [Abstract][Full Text] [Related]
15. [TET2 dysregulation in hematologic malignancies].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2014 Oct; 55(10):1893-902. PubMed ID: 25297753
[No Abstract] [Full Text] [Related]
16. [Advances in blastic plasmacytoid dendritic cell neoplasm].
Fan XS; Wang SA
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):131-4. PubMed ID: 23710925
[No Abstract] [Full Text] [Related]
17. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.
Tefferi A; Lim KH; Abdel-Wahab O; Lasho TL; Patel J; Patnaik MM; Hanson CA; Pardanani A; Gilliland DG; Levine RL
Leukemia; 2009 Jul; 23(7):1343-5. PubMed ID: 19295549
[No Abstract] [Full Text] [Related]
19. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
20. Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.
Kim M; Yahng SA; Kwon A; Park J; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Lee JW; Min WS; Lee SH; Kim YJ
Bone Marrow Transplant; 2015 Aug; 50(8):1132-4. PubMed ID: 25961778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
